No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs4682826 |
chr3:46705369-46705370 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs77717432 |
chr3:46705381-46705382 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs192137814 |
chr3:46705406-46705407 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs551076055 |
chr3:46705421-46705422 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs138761656 |
chr3:46705428-46705429 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs183961181 |
chr3:46705431-46705432 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs373824469 |
chr3:46705486-46705487 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs188467361 |
chr3:46705487-46705488 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs74975494 |
chr3:46705488-46705489 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs567987071 |
chr3:46705493-46705494 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs141717177 |
chr3:46705503-46705504 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs370608884 |
chr3:46705509-46705510 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs556494986 |
chr3:46705532-46705533 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs571686221 |
chr3:46705538-46705539 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs539121229 |
chr3:46705550-46705551 |
Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs4683261 |
chr3:46705622-46705623 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
17 |
rs371253755 |
chr3:46705669-46705670 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs939416 |
chr3:46705687-46705688 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
19 |
rs540461333 |
chr3:46705694-46705695 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs112297216 |
chr3:46705700-46705701 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs192138937 |
chr3:46705719-46705720 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs146248082 |
chr3:46705740-46705741 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs544946992 |
chr3:46705753-46705754 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs140071134 |
chr3:46705796-46705797 |
Weak transcription Enhancers Bivalent Enhancer Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs370468894 |
chr3:46705838-46705839 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs373360257 |
chr3:46705872-46705873 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs182502610 |
chr3:46705907-46705908 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs377752628 |
chr3:46705908-46705909 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs532797943 |
chr3:46705913-46705914 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs544680019 |
chr3:46705945-46705946 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs559859734 |
chr3:46706026-46706027 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs77263397 |
chr3:46706047-46706048 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs549511493 |
chr3:46706051-46706052 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs386660744 |
chr3:46706064-46706065 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs6762662 |
chr3:46706065-46706066 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
36 |
rs550243358 |
chr3:46706109-46706110 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs546886822 |
chr3:46706194-46706195 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs34437592 |
chr3:46706205-46706206 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs571647683 |
chr3:46706241-46706242 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs539083130 |
chr3:46706249-46706250 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs554299471 |
chr3:46706252-46706253 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs150821459 |
chr3:46706296-46706297 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs6442014 |
chr3:46706315-46706316 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
44 |
rs367652201 |
chr3:46706337-46706338 |
Weak transcription Bivalent Enhancer Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs139229963 |
chr3:46706494-46706495 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs544478601 |
chr3:46706511-46706512 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
47 |
rs370243527 |
chr3:46706528-46706529 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
48 |
rs939417 |
chr3:46706531-46706532 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
49 |
rs140586092 |
chr3:46706538-46706539 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
50 |
rs11269266 |
chr3:46706539-46706540 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|